Ocugen (OCGN) Liabilities and Shareholders Equity (2014 - 2026)

Ocugen (OCGN) posted Liabilities and Shareholders Equity of $56.9 million for Q1 2026, up 30.77% on a QoQ basis from $43.5 million in Q4 2025, and down 11.72% year-over-year from $64.5 million in Q1 2025.

Ocugen (OCGN) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Ocugen's Liabilities and Shareholders Equity history runs 13 years deep, the most recent figure standing at $56.9 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 11.72% year-over-year to $56.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $211.6 million (down 15.15% YoY) and the FY2025 annual result came in at $43.5 million, down 47.22% from the prior year.
  • Liabilities and Shareholders Equity was $56.9 million for Q1 2026 at Ocugen, up from $43.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $141.7 million in Q1 2022 and bottomed at $40.5 million in Q2 2024.
  • A 5-year average of $78.5 million and a median of $64.5 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 163.2% — and 2024, when it sank 54.43%.
  • Ocugen's Liabilities and Shareholders Equity stood at $108.6 million in 2022, then tumbled by 40.58% to $64.5 million in 2023, then climbed by 27.72% to $82.4 million in 2024, then plunged by 47.22% to $43.5 million in 2025, then soared by 30.77% to $56.9 million in 2026.
  • Business Quant data shows OCGN's Liabilities and Shareholders Equity at $56.9 million in Q1 2026, $43.5 million in Q4 2025, and $57.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 311.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 78.88 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.55 Bn
4 NuCana 279.75 Bn 279.75 Bn - 39.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 811.27 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 10.03 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.25 Bn
10 Ocugen 63.79 Mn 63.79 Mn - 56.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 56.91 Mn
Dec 31, 2025 43.52 Mn
Sep 30, 2025 57.60 Mn
Jun 30, 2025 53.59 Mn
Mar 31, 2025 64.46 Mn
Dec 31, 2024 82.44 Mn
Sep 30, 2024 61.94 Mn
Jun 30, 2024 40.54 Mn
Mar 31, 2024 51.79 Mn
Dec 31, 2023 64.55 Mn
Sep 30, 2023 74.69 Mn
Jun 30, 2023 88.98 Mn
Mar 31, 2023 96.30 Mn
Dec 31, 2022 108.63 Mn
Sep 30, 2022 116.24 Mn
Jun 30, 2022 130.09 Mn
Mar 31, 2022 141.73 Mn
Dec 31, 2021 105.76 Mn
Sep 30, 2021 116.31 Mn
Jun 30, 2021 124.25 Mn